On July 17, KENS5 reported on a woman who was taking Wegovy, a GLP-1, regularly for weight loss but was not made aware of the potential negative interactions leading up to a bronchoscopy.
Chaplain Treanor, the patient, went into her procedure having taken Wegovy days before, according to the report.
Ozempic is FDA-approved for diabetes treatment and Wegovy is FDA-approved for weight loss.
